Novartis Oncology Director of IT Salaries in New York | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Director of IT Salaries in New York

The average Novartis Oncology Director of IT in New York earns an estimated $163,228 annually. Novartis Oncology's Director of IT compensation is $12,385 more than the US average for a Director of IT.

In New York, The IT Department at Novartis Oncology earns $4,630 more on average than the HR Department.

Last updated 3 years ago.

$24k
$66k
$108k
$150k
$234k
$325k
$400k
$163,228
Average Compensation
$163,228
avg. base

Director of IT Salaries at Novartis Oncology

In New York, Directors of IT earn $19,313 more than IT Managers.

IT Manager
$144k*
SysAdmin
$113k*
IT Support Engineer
$84k*
Desktop Support
$64k*
* estimated salary

Compensation at Novartis Oncology by Department

In New York, The IT Department averages $4,630 more than the HR Department, and $178 less than the Sales Department

Sales
$114,739 Avg. total comp.
+$178
IT
$114,561 Avg. total comp.
HR
$109,931 Avg. total comp.
-$5k

Director of IT Compensation by Gender (All Companies)

The average female Director of IT at companies similar size to Novartis Oncology reported making $188,429, while the average male Director of IT at similar sized companies reported making $188,773.

Director of IT Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of IT at companies similar size to Novartis Oncology reported making $190,831, while the average Hispanic or Latino Director of IT at similar sized companies reported making $177,385.

How Directors of IT at Novartis Oncology Rate Their Compensation

The majority of Directors of IT at Novartis Oncology believe they're not compensated fairly. 100% of Directors of IT at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company